Corcept Therapeutics (CORT)
(Delayed Data from NSDQ)
$70.45 USD
-1.32 (-1.84%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $70.44 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Corcept Therapeutics Incorporated's dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CORT 70.45 -1.32(-1.84%)
Will CORT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CORT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CORT
CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down
Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates
CORT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last?
Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer
Should Invesco S&P SmallCap Momentum ETF (XSMO) Be on Your Investing Radar?
Other News for CORT
CORT: Today's Analyst Rating Update and Price Target Adjustment | CORT Stock News
Corcept Therapeutics (CORT) Target Price Revised by Piper Sandler Analyst
Corcept Therapeutics (CORT) Price Target Lowered, Buy Rating Maintained
ClearBridge Small Cap Fund Q2 2025 Commentary
Piper Sandler Lowers Price Target for Corcept Therapeutics (CORT) | CORT Stock News